Top 10 Pharma Companies in India
Here is a list of India’s Top 10 Pharma Companies in India based on Revenue in the Previous Year. ⭐⭐⭐⭐⭐ Take a look at the pharmaceutical industry.
By 2023, the worldwide pharmaceutical market is anticipated to be worth more than USD 1.5 trillion. In the global pharmaceutical business, India holds a significant place. India is the world’s leading generics supplier, accounting for 20% of global exports. It meets more than half of the global demand for vaccinations and 40% of the market for generic pharmaceuticals in the United States.
In terms of value, the domestic pharmaceutical market accounts for 2% of the worldwide industry and 10% in terms of volume. In the years 2019-23, India’s pharmaceutical spending is expected to expand at an annual rate of 8-11 percent, reaching US$ 28-32 billion.
List of Top Pharma Companies in India
Based on total net sales, here is the list of India’s Top 10 Pharma Companies. The order of the list is downward (10 – 1).
Divi’s Laboratories Ltd ( best pharma company in India )
Divis Laboratories manufactures Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical Ingredients, with an emphasis on exports. The firm’s total net sales are Rs 4880 crores. One of India’s best pharmaceutical companies.
- Market Cap: 57,919
- ROE: 01%
- Sales Growth (3Yrs): 41%
- Promoter holding: 00%
- Debt to equity: 00
- Price to book value: 18
Divi’s has been in business in Hyderabad, India, for more than 29 years and has two manufacturing facilities. It is one of India’s leading pharmaceutical enterprises. At Divi’s, 11,000 highly skilled workers from various departments and 350 scientists collaborate to deliver world-class products to clients.
Alkem Laboratories Ltd ( best pharma company in India )
Since 1973, the company has produced high-quality branded generics, generic medications, active pharmaceutical components, and nutraceuticals, which it sells in India and over 50 other countries.
The company has been ranked among the top ten pharmaceutical companies in India in terms of domestic sales for the past 15 years, with a comprehensive portfolio of over 750 products encompassing all key therapeutic areas and a solid pan-India sales and distribution network.
- Market Cap: 30,691
- ROE: 84%
- Sales Growth (3Yrs): 47%
- Promoter holding: 04%
- Debt to equity: 24
- Price to book value: 22
For more than a decade, the company has been designated India’s No. 1 Anti-infective company, and it is among the top pharmaceutical companies in the therapeutic areas of Gastro-intestinal, Pain Management, and Vitamins / Minerals / Nutrients.
In terms of domestic sales, the firm is now placed sixth in India, with notable names such as Clavam, Pan, Pan-D, Taxim, and Taxim-O ranking among the top 50 pharmaceutical brands in India for the fiscal year 2018.
With a total of 21 manufacturing facilities, including 19 in India and two in the United States, the company has a large manufacturing footprint. The firm’s total net sales are Rs 5714 crore. One of India’s best pharmaceutical companies.
Torrent Pharmaceuticals Ltd ( best pharma company in India )
Torrent Pharma, the parent company of the Torrent Group, is one of the country’s leading pharmaceutical corporations. The company was one of the first in India to introduce the notion of specialty marketing, and it is now a market leader in the therapeutic segments of cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), and women’s health (WHC).
Diabetology, pain management, obstetrics, oncology, and anti-infective segments are also important to the company.
The world-class manufacturing facilities, excellent R&D capabilities, vast domestic network, and global presence in over 40 countries provide Torrent Pharma a competitive advantage. The firm’s total net sales are Rs 5762 crores.
- Market Cap: 35,530
- ROE: 75%
- Sales Growth (3Yrs): 69%
- Promoter holding: 25%
- Debt to equity: 85
- Price to book value: 00
Torrent Pharma’s position in the Indian Pharma market was strengthened by the acquisitions of Elder Pharma’s Indian branded business in 2013, Zyg Pharma’s Dermaceutical business in 2015, Glochem Industries’ API plant in 2016, Novartis’ women healthcare brands in 2016, and Unichem’s Indian branded business along with its Sikkim Plant in 2017.
In 2005, Torrent Pharma began its overseas acquisitions with Pfizer’s 90-year-old Heumann to enter the German market. In 2015, bought an ANDA for minocycline from Ranbaxy for the US market.
Torrent also purchased Bio-Pharm, Inc. (BPI), a generic pharmaceuticals and over-the-counter (OTC) company situated in Levittown, Pennsylvania, in January 2018. One of India’s best pharmaceutical companies.
Glenmark Pharmaceuticals Ltd ( best pharma company in India )
Glenmark Pharmaceuticals is a multinational pharmaceutical firm based in the United States. New chemical entities (NCEs) and new biological entities (NBEs) are being developed by the company (NBEs).
The company is largely focused on Oncology, Respiratory, and Dermatology, and has multiple compounds in various stages of pre-clinical and clinical research.
- Market Cap: 7,505
- ROE: 20%
- Sales Growth (3Yrs): 27%
- Promoter holding: 59%
- Debt to equity: 60
- Price to book value: 27
The firm’s total net sales are Rs 6403 crores. It has 17 manufacturing sites and 5 research and development centers dedicated to improving people’s lives all over the world. The company is ranked among India’s top pharmaceutical corporations.
Cadila Healthcare Ltd ( best pharma company in India )
Zydus Cadila is based in Ahmedabad, India, and is the fourth-largest pharmaceutical company in the country. The company has manufacturing and research facilities in India’s Gujarat, Maharashtra, Goa, Himachal Pradesh, and Sikkim states, as well as the United States and Brazil.
Zydus’ Innovation programme is led by 1300 researchers working on differentiated medicines for the future across 19 facilities. The group is continually researching new ideas and concepts, from NCEs to vaccines, biosimilars, and specialised technologies.
- Market Cap: 26,228
- ROE: 66%
- Sales Growth (3Yrs): 78%
- Promoter holding: 88%
- Debt to equity: 69
- Price to book value: 55
The regulated markets of the United States, Europe (France and Spain), and the high-profile markets of Latin America and South Africa are all strongholds for Zydus’ global business. It is also well-represented in 25 other emerging markets around the world. The company’s overall revenue is Rs 6500 crores.
Dr. Reddy’s Laboratories Ltd ( best pharma company in India )
Dr. Reddy’s Laboratories, situated in Hyderabad, Telangana, India, is an Indian multinational pharmaceutical corporation.
In the Nifty Pharma Index, Dr. Reddy’s Laboratories Ltd has a 17.00 percent Stock Weighatage. The firm’s total revenue is Rs 14500 crores. In India’s top 10 pharmaceutical businesses, the company is ranked fifth.
- Market Cap: 50,867
- ROE: 61%
- Sales Growth (3Yrs): -0.26%
- Promoter holding: 76%
- Debt to equity: 17
- Price to book value: 30
Dr. Reddy’s produces and sells a wide range of medications in India and around the world. Over 190 pharmaceuticals, 60 active pharmaceutical ingredients (APIs) for drug manufacturing, diagnostic kits, critical care, and biotechnology goods are among the company’s offerings.
Cipla ( best pharma company in India )
Cipla is a renowned worldwide pharmaceutical firm that specialises in high-quality branded and generic pharmaceuticals. Healthcare professionals and patients all across the world rely on the company.
The company’s total revenue is Rs 16362 crore. In India’s top 10 pharmaceutical businesses, the company is ranked fourth.
- Market Cap: 34,358
- ROE: 62%
- Sales Growth (3Yrs): 87%
- Promoter holding: 65%
- Debt to equity: 23
- Price to book value: 20
The corporation is focusing more on the worldwide market by consolidating and deepening its presence in India, South Africa, the United States, and other growing economies.
Lupin ( best pharma company in India )
Lupin is a multinational pharmaceutical firm that produces branded and generic formulations, biotechnology products, active pharmaceutical ingredients (APIs), and specialty goods. The firm’s total revenue is Rs 16718 crores. Lupin has world-class production facilities in India, Japan, the United States, Mexico, and Brazil.
- Market Cap: 29,497
- ROE: 38%
- Sales Growth (3Yrs): 46%
- Promoter holding: 93%
- Debt to equity: 64
- Price to book value: 17
Lupin is a major player in the fields of gynecology, cardiology, diabetes, asthma, pediatrics, central nervous system (CNS), gastrointestinal (GI), anti-infectives (AI), and non-steroidal anti-inflammatory drugs (NSAIDs) (NSAIDs).
Lupin is also the market leader in the Anti-TB and Cephalosporins segments on a global scale. Lupin, which has a presence in over 100 countries, provides high-quality, inexpensive medications for some of the world’s most chronic diseases, solving unmet needs in many areas.
Aurobindo Pharma Ltd ( best pharma company in India )
Aurobindo Pharma was founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy, and a small group of dedicated professionals. The company began operations in Pondicherry in 1988-89 with a single unit producing Semi-Synthetic Penicillin (SSP). The company’s total revenue is Rs 19564 crore.
- Market Cap: 27,615
- ROE: 01%
- Sales Growth (3Yrs): 41%
- Promoter holding: 87%
- Debt to equity: 37
- Price to book value: 82
In 1992, Aurobindo Pharma became a public corporation, and in 1995, its shares were placed on Indian stock exchanges. It has a presence in major therapeutic categories such as neurosciences, cardiology, antiretrovirals, anti-diabetics, gastrointestinal, and anti-biotics, among others, in addition to being the market leader in Semi-Synthetic Penicillins.
Aurobindo Pharma is a fully integrated pharmaceutical company in India that ranks in the top two firms in terms of consolidated revenues. Aurobindo exports to approximately 150 countries throughout the world, with overseas activities accounting for more than 90% of its sales.
Taking use of India’s worldwide competitive cost base and excellent scientific team. Aurobindo Pharma is India’s second-largest pharmaceutical firm.
Sun PharmaceuticalsIndustries Ltd ( best pharma company in India )
It is a Mumbai-based Indian multinational pharmaceutical firm that makes and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) mostly in India and the United States.
In Nifty Pharma, Sun Pharmaceutical Industries Ltd has a 24.09 percent Stock Weightage. The company’s total revenue is Rs 29066 crores. Sun Pharma is India’s largest pharmaceutical company in terms of revenue and market capitalization.
- Market Cap: 94,378
- ROE: 19%
- Sales Growth (3Yrs): 67%
- Promoter holding: 56%
- Debt to equity: 25
- Price to book value: 28
Cardiology, psychiatry, neurology, gastrointestinal, and diabetology are among the therapeutic areas where the company produces formulations. It also sells anti-cancers, steroids, peptides, sex hormones, and regulated substances, as well as APIs including warfarin, carbamazepine, etodolac, and clorazepate.
|10.||Divi’s Laboratories Ltd|
|9.||Alkem Laboratories Ltd|
|8.||Torrent Pharmaceuticals Ltd|
|7.||Glenmark Pharmaceuticals Ltd|
|6.||Cadila Healthcare Ltd|
|5.||Dr. Reddy’s Laboratories Ltd|
|2.||Aurobindo Pharma Ltd|
|1.||Sun Pharmaceuticals Industries Ltd|
Pharma Companies in Hyderabad
- Aurobindo Pharma Ltd
- Divi’s Laboratories Ltd
- Dr. Reddy’s Laboratories Ltd
- Sri Krishna Pharmaceuticals Limited
- Biological E. Limited
Pharma Companies in Bangalore
- Novo Nordisk India
- Lotus Labs Private Limited
- Terzetto Pharma Metrics
- Aurigene Discovery Technologies Limited
- Bal Pharma Limited
Pharma Companies in Chennai
- Sun Pharmaceuticals Industries Ltd.
- Medopharm Private Limited (Corporate Office)
- Orchid Pharma Ltd
- Tablets (India) Limited
- The Madras Pharmaceuticals
THANKS FOR READING